tacrine has been researched along with Insulin Resistance in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, A | 1 |
| An, W | 1 |
| Wang, C | 1 |
| Hua, Y | 1 |
| Fang, F | 1 |
| Dong, X | 1 |
| Chen, R | 1 |
| Zhang, Z | 1 |
| Luo, L | 1 |
1 other study available for tacrine and Insulin Resistance
| Article | Year |
|---|---|
SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits.
Topics: Animals; Cell Line, Tumor; Cognitive Dysfunction; Dose-Response Relationship, Drug; Insulin Resistan | 2020 |